1. Home
  2. TRX vs HBIO Comparison

TRX vs HBIO Comparison

Compare TRX & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TRX Gold Corporation

TRX

TRX Gold Corporation

N/A

Current Price

$0.93

Market Cap

228.9M

Sector

N/A

ML Signal

N/A

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$0.76

Market Cap

33.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRX
HBIO
Founded
1990
1901
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
228.9M
33.8M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
TRX
HBIO
Price
$0.93
$0.76
Analyst Decision
Strong Buy
Buy
Analyst Count
2
3
Target Price
$1.25
$2.50
AVG Volume (30 Days)
1.6M
864.2K
Earning Date
01-13-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$57,613,000.00
$87,371,000.00
Revenue This Year
$28.16
N/A
Revenue Next Year
N/A
$7.22
P/E Ratio
$376.20
N/A
Revenue Growth
39.98
N/A
52 Week Low
$0.27
$0.28
52 Week High
$0.91
$2.28

Technical Indicators

Market Signals
Indicator
TRX
HBIO
Relative Strength Index (RSI) 71.36 58.99
Support Level $0.84 $0.74
Resistance Level $0.89 $0.84
Average True Range (ATR) 0.05 0.06
MACD 0.01 -0.01
Stochastic Oscillator 93.70 55.63

Price Performance

Historical Comparison
TRX
HBIO

About TRX TRX Gold Corporation

TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: